Pfizer PFE
NYSE PFE
$27.82 -0.43 (-1.52%)
At close: Aug 20, 2026 · 4:00 PM EDT

Pfizer (PFE) EBT Margin (2009 - 2026)

Pfizer (PFE) posted quarterly EBT Margin of 21.94% for Q1 2026, up 163.0% year-over-year from 8.34% in Q1 2025, and up 377.68% quarter-over-quarter from 4.59% in Q4 2025.

Pfizer (PFE) EBT Margin (2009 - 2026) Analysis & Trends

Pfizer (PFE) has reported EBT Margin for 18 consecutive years, with 21.94% the latest figure, recorded in Q1 2026.

  • In Q1 2026, EBT Margin rose 163.0% year-over-year to 21.94%; the TTM figure through Mar 2026 stood at 332.46% (down 34908.0% YoY), while the FY2025 annual figure was 81.16%, down 1449.0% from the prior year.
  • EBT Margin grew to 21.94% in Q1 2026 per PFE's latest filing, from 4.59% in the prior quarter.
  • Across five years, EBT Margin topped out at 172.87% in Q2 2023 and bottomed at 120.24% in Q4 2023.
  • Historically, EBT Margin has averaged 33.42% across 5 years, with a median of 21.94% in 2026.
  • Annual changes were most pronounced in 2023 — EBT Margin surged 13760 bps — and 2024, when it plunged 14988 bps.
  • Pfizer's EBT Margin stood at 41.26% in 2022, then sank by 391 bps to 120.24% in 2023, then surged by 115 bps to 17.51% in 2024, then tumbled by 74 bps to 4.59% in 2025, then soared by 378 bps to 21.94% in 2026.
  • Business Quant data shows PFE's EBT Margin at 21.94% in Q1 2026, 4.59% in Q4 2025, and 20.02% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 26.66%
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 25.18%
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn -4.11%
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 29.63%
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 18.19%
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 27.53%
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -131.41%
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -4.34%
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 4.21%
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 127.52%

Historic Data

Download Data
DateValue
Jun 28, 2026 -4.34%
Mar 29, 2026 21.94%
Dec 31, 2025 4.59%
Sep 28, 2025 20.02%
Jun 29, 2025 133.92%
Mar 30, 2025 20.31%
Sep 29, 2024 17.51%
Jun 30, 2024 -0.97%
Mar 31, 2024 22.99%
Dec 31, 2023 -120.24%
Jul 2, 2023 65.01%
Apr 2, 2023 172.87%
Jul 3, 2022 41.26%
Apr 3, 2022 35.27%
Oct 3, 2021 35.66%
Jul 4, 2021 36.77%
Apr 4, 2021 39.21%
Sep 27, 2020 21.30%
Jun 28, 2020 30.68%
Mar 29, 2020 28.19%